Exploring the Power of Machine Learning in Analysing Protein–Protein Sequences
IET Systems Biology · 2026
DOI: 10.1049/syb2.70066 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IET Systems Biology, 2026. Verfasst von Anindya Nag und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science & Engineering, Northern University of Business and Technology Khulna, Khulna, Bangladesh. Hauptthemen laut MEDLINE: Proteins, Machine Learning, Sequence Analysis, Protein, Computational Biology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proteins are fundamental biological macromolecules responsible for regulating nearly all cellular processes, and their functions are largely determined by the underlying amino acid sequences. Understanding the relationship between protein sequences and their structural and functional properties remains a major challenge in molecular biology. Although experimental techniques provide accurate insights, they are often time‐consuming and expensive, which has led to increasing reliance on computational approaches for protein sequence analysis and structure prediction. Numerous techniques—including homology modelling, machine learning, deep learning, natural language processing and other artificial intelligence methods—have been developed for analysing protein sequences and predicting protein–protein interactions. However, the rapidly growing number of computational methods makes it difficult for researchers to systematically evaluate and select suitable approaches for specific biological applications. This study presents a comprehensive review of recent computational techniques for protein sequence analysis, focusing on machine learning‐ and deep learning‐based frameworks used for predicting protein structure and interactions. This review systematically categorises existing approaches based on their methodological foundations, datasets and performance characteristics and provides a comparative discussion of their advantages and limitations. Furthermore, this study highlights current research gaps, challenges in large‐scale protein analysis and emerging trends in AI‐driven protein modelling. The findings of this review provide a structured reference for researchers and practitioners, facilitating the selection of appropriate computational techniques and supporting future advancements in protein sequence analysis, disease research and drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computer Science & Engineering, Northern University of Business and Technology Khulna, Khulna, Bangladesh.
- Department of Computer Science and Engineering, Brainware University, Kolkata, India.
- Computer Science and Engineering Discipline, Khulna University, Khulna, Bangladesh.
- Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
- Department of Computer Science and Engineering, Adamas University, Kolkata, India.
- Department of Computer Applications, Sri Satya Sai University of Technology and Medical Sciences (SSSUTMS), Sehore, Madhya Pradesh, India.
ORCID-Profile: Anindya Nag, Anurag Sinha
Zitieren
APA
Nag, A., Sil, R., Hassan, M. M., Ritu, T. H., Das, B., Roy, N., Sinha, A., Guin, D., & Maurya, N. (2026). Exploring the Power of Machine Learning in Analysing Protein–Protein Sequences. IET Systems Biology. https://doi.org/10.1049/syb2.70066
Vancouver
Nag A, Sil R, Hassan MM, Ritu TH, Das B, Roy N, et al. Exploring the Power of Machine Learning in Analysing Protein–Protein Sequences. IET Systems Biology. 2026. doi:10.1049/syb2.70066
BibTeX
@article{Nag2026,
author = {Nag, Anindya and Sil, Riya and Hassan, Md Mehedi and Ritu, Tamanna Haque and Das, Biva and Roy, Nilanjana and Sinha, Anurag and Guin, Dron and Maurya, Nishchal},
title = {Exploring the Power of Machine Learning in Analysing Protein–Protein Sequences},
journal = {IET Systems Biology},
year = {2026},
doi = {10.1049/syb2.70066}
}
EUVIMED